Protocol Ledger

Academic / Institutional Sponsor · Consolidated Sponsor Hub

Shahid Beheshti University of Medical Sciences: Clinical Trials & FDA Approval Profile

Shahid Beheshti University of Medical Sciences (Global / Institutional) sponsors 34 reconciled interventional Phase II and Phase III ClinicalTrials.gov studies (2018 to 2026), including 2 active protocols (0 recruiting now), 5 completed protocols, and 0 all-time original FDA Drugs@FDA NDA and BLA approvals.

Track in Studio / Generate Client Brief ->
Early-Stop Rate vs National (13.8%)2.9%
Median Closed Enrollment vs National (145 pts)30 participants

Verified Sponsor Execution & Regulatory Ledger

Reconciled ClinicalTrials.gov v2 & Drugs@FDA Metrics for Shahid Beheshti University of Medical Sciences
Sponsor MetricVerified Count / Rate
Phase II & III Protocols (2018 to 2026)34
Active Pipeline (Recruiting Now)2 (0)
Completed vs Stopped Early5 / 1 (2.9%)
Median Closed Actual Enrollment30 participants
Physical Hospital Site Disclosure100.0% named hospitals
FDA Drugs@FDA Original NDA/BLA Approvals0 (0 since 2018)

Explore interactive annual charts and M&A subsidiary rollups in the Shahid Beheshti University of Medical Sciences Interactive Dossier, benchmark peers in Ophthalmology and Sensory, or review the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI